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Abstract – The release of growth factors from tissue 
engineering scaffolds provides signals that 
influence the migration, differentiation, and 
proliferation of cells.  The incorporation of a drug 
delivery platform that is capable of tunable release 
will give tissue engineers greater versatility in the 
direction of tissue regeneration.  We have prepared 
a novel composite of two biomaterials with proven 
track records - apatite and poly(lactic-co-glycolic 
acid) (PLGA) – as a drug delivery platform with 
promising controlled release properties.  These 
composites have been tested in the delivery of a 
model protein, bovine serum albumin (BSA), as 
well as therapeutic proteins, recombinant human 
bone morphogenetic protein-2 (rhBMP-2) and 
rhBMP-6.  The controlled release strategy is based 
on the use of a polymer with acidic degradation 
products to control the dissolution of the basic 
apatitic component, resulting in protein release.  
Therefore, any parameter that affects either 
polymer degradation or apatite dissolution can be 
used to control protein release.  We have modified 
the protein release profile systematically by 
varying the polymer molecular weight, polymer 
hydrophobicity, apatite loading, apatite particle 
size, and other material and processing 
parameters.  Biologically active rhBMP-2 was 
released from these composite microparticles over 
100 days, in contrast to conventional collagen 
sponge carriers, which were depleted in 
approximately 2 weeks.  The released rhBMP-2 
was able to induce elevated alkaline phosphatase 
and osteocalcin expression in pluripotent murine 
embryonic fibroblasts.   
 
To augment tissue engineering scaffolds with 
tunable and sustained protein release capabilities, 
these composite microparticles can be dispersed in 
the scaffolds in different combinations to obtain a 
superposition of the release profiles.  We have 
loaded rhBMP-2 into composite microparticles 
with a fast release profile, and rhBMP-6 into slow-
releasing composite microparticles.  An equi-
mixture of these two sets of composite particles was 
then injected into a collagen sponge, allowing for 
dual release of the proteins from the collagenous 
scaffold.  The ability of these BMP-loaded scaffolds 
to induce osteoblastic differentiation in vitro and 
ectopic bone formation in a rat model is being 
investigated.   
 
We anticipate that these apatite-polymer composite 
microparticles can be extended to the delivery of 
other signalling molecules, and can be incorporated 
into other types of tissue engineering scaffolds. 
 
